Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Archive Search

1 results
12:00 AM, Oct 02, 2014  |  BC Innovations | Strategy

A conversation with Jeffrey Settleman

inhibitors approved in U.S. by year. Counts for 2014 exclude Chugai Pharmaceutical Co. Ltd. 's Alecensa
alectinib, a small molecule anaplastic lymphoma kinase ( ALK ) inhibitor marketed in Japan to treat …